Yelin Lapidot Holdings Management Ltd. Decreases Holdings in Perrigo Company plc (NYSE:PRGO)

Yelin Lapidot Holdings Management Ltd. trimmed its position in Perrigo Company plc (NYSE:PRGO - Free Report) by 4.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 267,915 shares of the company's stock after selling 12,644 shares during the period. Perrigo comprises 1.2% of Yelin Lapidot Holdings Management Ltd.'s investment portfolio, making the stock its 23rd biggest position. Yelin Lapidot Holdings Management Ltd. owned approximately 0.20% of Perrigo worth $6,888,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Versant Capital Management Inc purchased a new position in shares of Perrigo in the 4th quarter worth about $45,000. GAMMA Investing LLC boosted its stake in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock valued at $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division grew its position in shares of Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares during the period. Venturi Wealth Management LLC purchased a new stake in shares of Perrigo during the 3rd quarter worth approximately $56,000. Finally, KBC Group NV raised its holdings in shares of Perrigo by 25.1% in the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after purchasing an additional 905 shares during the period. Hedge funds and other institutional investors own 95.91% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

PRGO has been the subject of a number of recent research reports. StockNews.com downgraded Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Argus cut Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Finally, Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and cut their target price for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $33.00.

Perrigo Price Performance

PRGO traded up $0.37 during trading on Tuesday, reaching $29.37. 3,037,248 shares of the company were exchanged, compared to its average volume of 1,490,928. The company's 50-day moving average is $25.00 and its two-hundred day moving average is $26.20. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $33.46. The company has a market cap of $4.01 billion, a price-to-earnings ratio of -25.10 and a beta of 0.54. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.20 billion. Research analysts forecast that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be paid a dividend of $0.29 per share. This is a positive change from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. This represents a $1.16 annualized dividend and a yield of 3.95%. Perrigo's dividend payout ratio (DPR) is currently -92.80%.

Insider Buying and Selling

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now owns 5,409 shares of the company's stock, valued at $152,912.43. This represents a 76.49 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.70% of the stock is owned by company insiders.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.